PMID: 8610217Jan 1, 1995Paper

Primary Sjögren's syndrome (SS) and malignant lymphoma. A retrospective cohort study of 55 patients with SS

Scandinavian Journal of Rheumatology
P ZuffereyM F Kahn

Abstract

The aim of this study was to assess the prevalence of malignant lymphomas in patients with long-standing primary Sjögren's syndrome (pSS). We retrospectively studied a cohort of 55 patients with pSS over a mean follow-up period of 12 years. Five patients (9%) developed malignant lymphoma. The interval between the diagnoses of SS and lymphoma ranged from four to 12 years (mean = 6.5 years). The lymphoma arose in the lymph nodes in two cases, the parotid gland in one case, the lacrimal gland in one case, and the lung in one case. All five cases were B-cell low-grade lymphomas. Among our SS patients, those with extraglandular manifestations and/or a mixed cryoglobulin were at increased risk for lymphoma development. Secondary lymphoma carried a poor prognosis in our study. Three of the six SS patients who died during the follow-up period had lymphoma.

References

Dec 1, 1978·Annals of Internal Medicine·S S KassanT M Chused
Nov 30, 1978·The New England Journal of Medicine·J ZulmanN Talal
Jan 1, 1992·International Journal of Clinical & Laboratory Research·C A Kelly
Jan 1, 1992·Medical and Pediatric Oncology·N A PavlidisH M Moutsopoulos
Aug 1, 1989·Mayo Clinic Proceedings·L A HansenT V Colby
Apr 30, 1987·The New England Journal of Medicine·A FishlederH Levine
Feb 1, 1988·International Journal for Parasitology·G WoutersA Calus
Apr 1, 1964·The American Journal of Medicine·N TALAL, J J BUNIM

❮ Previous
Next ❯

Citations

Jul 28, 2007·Inflammopharmacology·A L Parke, W W Buchanan
Jul 12, 2011·Journal of Clinical Immunology·Clothilde MartelAnne Laure Fauchais
Dec 10, 2003·Oral Oncology·Chris T DerkSergio A Jimenez
Aug 19, 2004·Current Opinion in Pulmonary Medicine·Vasken Artinian, Paul A Kvale
Jan 8, 2008·Southern Medical Journal·Paola Caramaschi, Domenico Biasi
Jun 25, 1999·Annals of the Rheumatic Diseases·M PertovaaraA Pasternack
Nov 27, 2004·Acta Haematologica·Po DunnChung-Chih Tang
Dec 3, 2009·Internal Medicine·Mitsuhiro SunoharaTetsuya Hisada
Jan 1, 2007·Women's Health·Ibtisam Al-Hashimi
Aug 29, 2014·Arthritis Research & Therapy·Sung Hae ChangEun Bong Lee
Feb 28, 2015·PloS One·Aristea PapageorgiouMichael Voulgarelis
Jul 23, 2016·Immunologic Research·Andreas V Goules, Athanasios G Tzioufas
Jan 1, 1996·Scandinavian Journal of Rheumatology·J A HernándezE Feliu
Nov 10, 1998·Scandinavian Journal of Rheumatology·C García-PorrúaM J García-Pais
May 12, 2012·Nihon Rinshō Men'eki Gakkai kaishi = Japanese journal of clinical immunology·Hiroyuki YamashitaAkio Mimori
Jul 28, 2019·Expert Review of Clinical Immunology·Salvatore De Vita, Saviana Gandolfo
Jul 30, 2003·Journal of Computer Assisted Tomography·Hisao TonamiSusumu Sugai
Oct 4, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Long ShenJulian L Ambrus
Aug 10, 2002·Medicine·Manuel Ramos-CasalsMiguel Ingelmo
Feb 24, 2006·Rheumatology·M N LazarusD A Isenberg
Aug 19, 2020·Journal of Clinical Medicine·Loukas ChatzisAndreas V Goules
Nov 17, 2020·Frontiers in Immunology·Andreas V GoulesAthanasios G Tzioufas
Mar 6, 2021·Journal of Translational Autoimmunity·Coad Thomas Dow, Edward D Chan
Aug 1, 1997·Clinical Immunology and Immunopathology·A S BansalE E Powell
Nov 7, 1998·Seminars in Arthritis and Rheumatism·N SutcliffeD Isenberg
Sep 1, 1999·Seminars in Arthritis and Rheumatism·J E NaschitzD Yeshurun

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.